Catalyst Pharmaceutical CPRX Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Catalyst Pharmaceutical’s reported figures.
Based on trailing twelve months.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's return on invested capital?
- Catalyst Pharmaceutical (CPRX) reported return on invested capital of 83.9% in Q1 2026.
- How has Catalyst Pharmaceutical's return on invested capital changed year-over-year?
- Catalyst Pharmaceutical's return on invested capital increased by 11.9% year-over-year, from 75% to 83.9%.
- What is the long-term trend for Catalyst Pharmaceutical's return on invested capital?
- Over 4 years (2021 to 2025), Catalyst Pharmaceutical's return on invested capital has grown at a -4.0% compound annual growth rate (CAGR), from 99.4% to 84.5%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.